Loading…
Fredun Pharmaceuticals (FREDUN)₹1,519−0.13%Pharmaceuticals
At the end of the Sep 2026 quarter, Fredun Pharmaceuticals' shareholders were: promoters 44.56%, FIIs 1.05%, DIIs 2.93%, public 51.46%. Promoter holding is unchanged on the quarter. FII holding is up 1.04 percentage points from 0.01% a year earlier. 0.00% of promoter shares were pledged. It had 9,597 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 49.15% | 49.16% | 49.16% | 48.92% | 48.92% | 48.92% | 48.92% | 48.92% | 43.05% | 44.16% | 44.56% | 44.56% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.46% | 1.05% | 1.05% | 1.05% |
| DIIs | 1.59% | 1.59% | 1.59% | 1.58% | 1.58% | 1.58% | 1.58% | 1.60% | 3.47% | 2.82% | 2.93% | 2.93% |
| Public | 49.26% | 49.25% | 49.25% | 49.50% | 49.50% | 49.50% | 49.50% | 49.47% | 53.02% | 51.97% | 51.46% | 51.46% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 6,836 | 7,506 | 7,510 | 8,017 | 8,120 | 7,975 | 7,905 | 8,119 | 8,764 | 8,337 | 8,902 | 9,597 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Daulat Nariman Medhora | Promoter | 39.43% | 0.00 |
| Nikhil Kishorchandra Vora | Public | 5.46% | New |
| Fredun Nariman Medhora | Promoter | 5.17% | 0.00 |
| Capri Global Ventures Private Limited | Public | 1.46% | New |
| Bank Of India | DII | 1.37% | 0.00 |
| Arun Kumar Mukherjee | Public | 1.25% | New |
| Nav Capital Vcc - Nav Capital Emerging Star Fund | FII | 1.01% | 0.00 |
| Nariman Bamansha Medhora | Promoter | 0.01% | 0.00 |
Promoters held 44.56% of Fredun Pharmaceuticals at the end of the Sep 2026 quarter, down 4.36 percentage points from 48.92% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 1.05% (unchanged at 1.05% a quarter earlier) and domestic institutions (DIIs) held 2.93% (unchanged at 2.93% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Fredun Pharmaceuticals had 9,597 shareholders at the end of the Sep 2026 quarter, against 8,119 a year earlier.
Nikhil Kishorchandra Vora (Public) held 5.46% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.